BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 367155)

  • 1. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma.
    Schwarts SS; Zeidler A; Moossa AR; Kuku SF; Rubenstein AH
    Am J Dig Dis; 1978 Dec; 23(12):1107-14. PubMed ID: 367155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells.
    Hamaguchi T; Fukushima H; Uehara M; Wada S; Shirotani T; Kishikawa H; Ichinose K; Yamaguchi K; Shichiri M
    Diabetologia; 1991 Nov; 34(11):801-6. PubMed ID: 1769438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal pancreatic alpha-cell function in first-degree relatives of known diabetics.
    Kirk RD; Dunn P; Smith JR; Beaven DW; Donald RA
    J Clin Endocrinol Metab; 1975 May; 40(5):913-6. PubMed ID: 1092713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of islet-cell function in man.
    Arky RA; Knopp RH
    N Engl J Med; 1971 Nov; 285(20):1130-1. PubMed ID: 4937863
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormal insulin secretion in carcinoma of the pancreas: response to glucagon stimulation.
    Fox JN; Frier BM; Armitage M; Ashby JP
    Diabet Med; 1985 Mar; 2(2):113-6. PubMed ID: 2952394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet hormone secretion in pancreatic cancer patients with diabetes.
    Permert J; Larsson J; Fruin AB; Tatemoto K; Herrington MK; von Schenck H; Adrian TE
    Pancreas; 1997 Jul; 15(1):60-8. PubMed ID: 9211494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure.
    Melenovsky V; Benes J; Franekova J; Kovar J; Borlaug BA; Segetova M; Tura A; Pelikanova T
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28784650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T; Ohneda A; Nihei J; Kobayashi T
    Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
    Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and glucagon secretion by pancreatic islets from nondiabetic and diabetic sand rats (Psammomys obesus).
    Hahn HJ; Schäfer H; Gottschling HD; Fiedler H
    Eur J Clin Invest; 1976 Jan; 6(1):85-91. PubMed ID: 767120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of biotin deficiency on pancreatic islet morphology, insulin sensitivity and glucose homeostasis.
    Larrieta E; Vega-Monroy ML; Vital P; Aguilera A; German MS; Hafidi ME; Fernandez-Mejia C
    J Nutr Biochem; 2012 Apr; 23(4):392-9. PubMed ID: 21596550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin and diabetes.
    Gerich JE
    Am J Med; 1981 Mar; 70(3):619-26. PubMed ID: 6111219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon and insulin secretion in potential diabetes.
    Tiengo A; Fedele D; Muggeo M; Nosadini R; Molinari M; Garotti MC; Crepaldi G
    Acta Diabetol Lat; 1978; 15(3-4):143-51. PubMed ID: 360748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell functional pathology.
    Lacy PE
    Pathol Annu; 1977; 12 Pt 1():1-15. PubMed ID: 199881
    [No Abstract]   [Full Text] [Related]  

  • 18. The glucagonoma syndrome: surgically curable diabetes.
    Higgins GA; Recant L; Fischman AB
    Am J Surg; 1979 Jan; 137(1):142-8. PubMed ID: 215044
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic endocrine function in patients with intrathoracic replacement after esophagectomy.
    Sudo T; Shiraha S; Ishiyama K; Takemoto M; Kawamura M; Umemura H; Kuyama T
    World J Surg; 1983 Mar; 7(2):253-9. PubMed ID: 6346701
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo glucose-stimulated amylin secretion is increased in nondiabetic patients with pancreatic cancer.
    Mäkimattila S; Hietaniemi K; Kiviluoto T; Timonen T; Yki-Järvinen H
    Metabolism; 2001 Sep; 50(9):1036-42. PubMed ID: 11555835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.